Is an SGLT2 inhibitor right for your patient with type 2 diabetes?

被引：0
作者：
Lisenby, Katelin M. [1 ]
Meyer, Allison [1 ]
Slater, Nicole A. [1 ]
机构：
[1] Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Tuscaloosa, AL USA
来源：
JOURNAL OF FAMILY PRACTICE | 2016年 / 65卷 / 09期
关键词：
INADEQUATE GLYCEMIC CONTROL; METFORMIN PLUS SULFONYLUREA; LONG-TERM EFFICACY; ADD-ON THERAPY; DOUBLE-BLIND; BACKGROUND METFORMIN; SAFETY; EMPAGLIFLOZIN; PLACEBO; CANAGLIFLOZIN;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：587 / 593
页数：7
相关论文
共 50 条
[21]   Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus [J].
Fioretto, Paola ;
Giaccari, Andrea ;
Sesti, Giorgio .
CARDIOVASCULAR DIABETOLOGY, 2015, 14
[22]   SGLT2 inhibitors in the management of type 2 diabetes [J].
Reddy, R. P. Monica ;
Inzucchi, Silvio E. .
ENDOCRINE, 2016, 53 (02) :364-372
[23]   Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus [J].
Ribola, F. A. ;
Cancado, F. B. ;
Schoueri, J. H. M. ;
De Toni, V. F. ;
Medeiros, V. H. R. ;
Feder, D. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) :199-211
[24]   Does SGLT2 Inhibition Affect Sympathetic Nerve Activity in Type 2 Diabetes? [J].
Dimova, Rumyana ;
Tankova, Tsvetalina .
HORMONE AND METABOLIC RESEARCH, 2021, 53 (02) :75-84
[25]   SGLT2 Inhibitors in Type 2 Diabetes Mellitus [J].
Ferrannini, Giulia ;
Savarese, Gianluigi ;
Cosentino, Francesco .
HEART FAILURE CLINICS, 2022, 18 (04) :551-559
[26]   SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes [J].
Wu, Qian ;
Zhang, Jian ;
Zhang, Fuli ;
Li, Dongnan .
FRONTIERS IN ENDOCRINOLOGY, 2025, 16
[27]   Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus [J].
Solini, Anna .
ACTA DIABETOLOGICA, 2016, 53 (06) :863-870
[28]   Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin [J].
Jabbour, Serge A. ;
Whaley, Jean M. ;
Tirmenstein, Mark ;
Poucher, Simon M. ;
Reilly, Timothy P. ;
Boulton, David W. ;
Saye, JoAnne ;
List, James F. ;
Parikh, Shamik .
POSTGRADUATE MEDICINE, 2012, 124 (04) :62-73
[29]   A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor [J].
Jung, Chang Hee ;
Jang, Jung Eun ;
Park, Joong-Yeol .
DIABETES & METABOLISM JOURNAL, 2014, 38 (04) :261-273
[30]   The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review [J].
Janet B. McGill .
Diabetes Therapy, 2014, 5 :43-63
12345